Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial

Details 詳細情報について

• CRID

  1360580934791728768

• DOI

  10.1007/s40744-023-00593-7

• ISSN

  21986584

  21986576

• Web Site

  https://link.springer.com/content/pdf/10.1007/s40744-023-00593-7.pdf

  https://link.springer.com/article/10.1007/s40744-023-00593-7/fulltext.html

• Data Source

  • Crossref